On Nov 3, 2021 Antios Therapeutics closed a Series B round and raised $75,000,000 from Adage Capital Management, Aisling Capital, Altium Capital, Amzak Health Investors, Avego Bioscience Capital, CAM Capital, Delos Capital, Domain Associates, EPIQ Capital Group, Fonds de solidarité FTQ, GordonMD Global Investments, GRA Venture Fund, LLC, Granite Point Capital, Heartland Healthcare Capital, LifeSci Venture Partners, Lumira Ventures, Pontifax, RA Capital Management, Sixty Degree Capital, Soleus Capital, featuring lead investors EPIQ Capital Group, GordonMD Global Investments.

About the company: Antios Therapeutics is located at United States, North America.
“”

Company website: http://www.antiostherapeutics.com